GlassScriptPhysician profile
Anne Cossogue
NPI 1649899527
$4,222.51
in general payments reported to CMS, 2019-2025
26 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,234 · 2024: $1,706 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,750 · Travel and Lodging: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.19 |
| Travel and Lodging | $1,472.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $811.42 | 2023 | Prostep |
| Medical Device Business Services, INC. | $779.90 | 2024 | |
| Kerecis Limited | $337.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $316.36 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $287.89 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $273.80 | 2023-2025 | Puraply, Via Matrix |
| Depuy Synthes Sales INC. | $247.18 | 2024 | Motoband, Vivigen Mis Delivery System, Minibunion |
| Tricoast Surgical Solutions LLC | $172.20 | 2024 | |
| Smith+Nephew, INC. | $154.47 | 2023-2025 | Grafix Pl, Stravix, Stravix Pl |
| Abbvie INC. | $130.53 | 2023-2025 | Dalvance |
| Vertex Pharmaceuticals Incorporated | $116.60 | 2024-2025 | |
| Mimedx Group, INC. | $105.46 | 2025 | |
| Medtronic, INC. | $84.34 | 2024 | Intellis Adaptivestim |
| Ani Pharmaceuticals, INC. | $64.85 | 2025 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $56.63 | 2023-2025 | Qutenza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $45.97 | 2025 | Proclaim |
| Paragon 28, INC. | $40.62 | 2024 | Precision Guide Lapidus |
| Aroa Biosurgery Incorporated | $38.75 | 2025 | |
| Globus Medical, INC. | $26.23 | 2025 | Senza |
| Integra Lifesciences Corporation | $25.48 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $23.83 | 2025 | Stimulan |
| Zimvie INC. | $20.26 | 2023 | |
| Solventum Corporation | $20.19 | 2024 | Activ.A.C. |
| Acumed LLC | $16.61 | 2023 | Acumed, Osteomed |
| Kowa Pharmaceuticals America, INC. | $15.05 | 2023 | Seglentis |
| Next Science LLC | $10.44 | 2023 | Blastx, Xperience, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Cossogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.